AKT1 and acute promyelocytic leukemia: Thus, AKT inhibition by PML::RARα, with inefficient primary cytoplasmic glycolysis and subsequent pyruvate scarcity must be the cause of the inability to utilize the glycolytic pathway for APL’s cells metabolic needs.